MARKET RESEARCH ON
  ANTI-HIV DRUGS

         BY

  SHRAVAN PASWAN




paswanshravan@gmail.com
INTRODUCTION
   MARKET: - Marketing is designing of products
    acceptable to the consumers & conduct of those
    activities which facilitate the transfer of ownership
    between buyer & seller.

   MARKETING RESEARCH: -It is defined as the
    objective & formal process of systematically
    obtaining, analyzing & interpreting data for
    actionable decision making in marketing.
PROCESSES OF MARKETING
          RESEARCH:-
   Establishing the need for the marketing research.
   Defining the problem.
   Establishing the research objective.
   Establishing the research design.
   Sources of data.
   Data collection.
   Analyzing data.
   Preparation of report.
ANTI HIV DRUGS
   HIV—The Human Immunodeficiency Virus is
    the Retrovirus that causes AIDS.
   HIV belongs to the Retrovirus subfamily
    Lentivirus.
   HIV attaches to the cells with CD4 receptors
    (T4 Cells & macrophages
CLASSIFICATION OF ANTI HIV
          DRUGS
   Nucleoside reverse Transcriptase
    Inhibitor Ex—Zidovudine, Zalcitabine

   Non Nucleoside Reverse Transcriptase
    Inhibitor Ex- Nevirapine, Delaveridine

   Protease Inhibitor:-- Ex- Saquinavir,
    Ritonavir
NAME OF COMPANIES WHICH
  MANUFACTURE GENERIC
 DRUGS FOR HIV INFECTION:-
   Barr Laboratories
   Pharma Limited
   Cipla Limited
   Ranbaxy Limited
   Matrix Limited
   Aurobindo Pharma Limited
   GSK
COST PER MONTH OF ANTIHIV
         DRUGS:-
   DRUGS        COST IN DOLLER
   Aptivus      $ 1117.50
   Combivir     $ 752.64
   Emtriva      $ 347.11
   Epivir       $ 347.11
   Epzicom      $ 813.55
   Hivid        $ 273.00
   Lexiva       $ 658.99
   Norvir        $ 321.46
   Rescriptor    $ 316.35
PHARMACEUTICAL MARKET
   OVERVIEW IN INDIA
EXPORT OF
PHARMACEUTICALS BY INDIA
PER CAPITA ANTIRETROVIRAL DRUG COSTS
     US DOLLARS (US$ BILLIONS), BY
        GEOGRAPHIC REGIONS:-
BIBLIOGRAPHY

   Barrar, F.S.K., “Essentials of Pharmacotherapeutics”,
    S. Chand & company, Ed-4th, 2008, Page no. 143-
    151.
   Goodman & Gillman, “The Pharmacological Basis of
    Therapeutics”, McGraw Hill Publishers, Ed-11th
    2007, Page no-429-452.
   Golane David, Armstrong, W. April, “Principles of
    Pharmacology”, Lipincott Willion & Wilkins, Ed-
    2nd, 2008, Page no. 215-218.
   Gulathi C.M., “MIMS”,Indraprastha Press ,Vol- 28,
    2008, Page no.118-127
   Tripathi, K.D., “Essentials of Medical
    Pharmacology”, Jaypee Publishers, Ed-6th
    2008, Page no-439-448.
   Vidya Sagar, “ Pharmaceutical Industrial
    Management” , Pragati Prakashan, Ed – 1st ,
    Page no- 33
THANKS

Anti hiv drugs

  • 1.
    MARKET RESEARCH ON ANTI-HIV DRUGS BY SHRAVAN PASWAN paswanshravan@gmail.com
  • 2.
    INTRODUCTION  MARKET: - Marketing is designing of products acceptable to the consumers & conduct of those activities which facilitate the transfer of ownership between buyer & seller.  MARKETING RESEARCH: -It is defined as the objective & formal process of systematically obtaining, analyzing & interpreting data for actionable decision making in marketing.
  • 3.
    PROCESSES OF MARKETING RESEARCH:-  Establishing the need for the marketing research.  Defining the problem.  Establishing the research objective.  Establishing the research design.  Sources of data.  Data collection.  Analyzing data.  Preparation of report.
  • 4.
    ANTI HIV DRUGS  HIV—The Human Immunodeficiency Virus is the Retrovirus that causes AIDS.  HIV belongs to the Retrovirus subfamily Lentivirus.  HIV attaches to the cells with CD4 receptors (T4 Cells & macrophages
  • 5.
    CLASSIFICATION OF ANTIHIV DRUGS  Nucleoside reverse Transcriptase Inhibitor Ex—Zidovudine, Zalcitabine  Non Nucleoside Reverse Transcriptase Inhibitor Ex- Nevirapine, Delaveridine  Protease Inhibitor:-- Ex- Saquinavir, Ritonavir
  • 6.
    NAME OF COMPANIESWHICH MANUFACTURE GENERIC DRUGS FOR HIV INFECTION:-  Barr Laboratories  Pharma Limited  Cipla Limited  Ranbaxy Limited  Matrix Limited  Aurobindo Pharma Limited  GSK
  • 7.
    COST PER MONTHOF ANTIHIV DRUGS:-  DRUGS COST IN DOLLER  Aptivus $ 1117.50  Combivir $ 752.64  Emtriva $ 347.11  Epivir $ 347.11  Epzicom $ 813.55  Hivid $ 273.00  Lexiva $ 658.99  Norvir $ 321.46  Rescriptor $ 316.35
  • 8.
    PHARMACEUTICAL MARKET OVERVIEW IN INDIA
  • 9.
  • 11.
    PER CAPITA ANTIRETROVIRALDRUG COSTS US DOLLARS (US$ BILLIONS), BY GEOGRAPHIC REGIONS:-
  • 12.
    BIBLIOGRAPHY  Barrar, F.S.K., “Essentials of Pharmacotherapeutics”, S. Chand & company, Ed-4th, 2008, Page no. 143- 151.  Goodman & Gillman, “The Pharmacological Basis of Therapeutics”, McGraw Hill Publishers, Ed-11th 2007, Page no-429-452.  Golane David, Armstrong, W. April, “Principles of Pharmacology”, Lipincott Willion & Wilkins, Ed- 2nd, 2008, Page no. 215-218.  Gulathi C.M., “MIMS”,Indraprastha Press ,Vol- 28, 2008, Page no.118-127
  • 13.
    Tripathi, K.D., “Essentials of Medical Pharmacology”, Jaypee Publishers, Ed-6th 2008, Page no-439-448.  Vidya Sagar, “ Pharmaceutical Industrial Management” , Pragati Prakashan, Ed – 1st , Page no- 33
  • 14.